Health Care Climbs as Pfizer, GSK Rise -- Health Care Roundup

Dow Jones05-02

Health-care companies rose after generally strong earnings.

Pfizer shares surged, rising by more than 5%, after the drug giant said sales of blood thinner Eliquis and oncology drugs offset a slide in sales of its Paxlovid Covid 19 treatment.

CVS shares fell to a three-year low after the drug-store chain and insurance firm said up-take at its Medicare business weighed on first-quarter earnings.

GSK shares rose after the British drug giant said demand for HIV drugs, and vaccines for various conditions including RSV boosted quarterly sales.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

May 01, 2024 17:25 ET (21:25 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment